Optimism, Mixed Results for New-Gen LVADs vs Mainstay HeartMate 2 Optimism, Mixed Results for New-Gen LVADs vs Mainstay HeartMate 2

Differently designed pumps, as more are approved, could be matched to patients ' unique risk-factor profiles for a patient-centric approach to cutting bleeding or infection risk, propose researchers.Heartwire from Medscape
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Cardiology News Source Type: news